Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Merck-Gilead first-of-its-kind combo pill scores in 2 HIV trials
A combo pill from Merck and Gilead has succeeded in two phase 3 trials and is set up to become the first oral HIV treatment that can be taken weekly.
Kevin Dunleavy
Jun 9, 2026 11:20am
Gilead's Trodelvy stumbles in first-line NSCLC
Jun 9, 2026 11:14am
AstraZeneca reprimanded over LinkedIn likes once again
Jun 9, 2026 6:16am
The Oral GLP-1 Tracker: Oral Wegovy hits 3M prescription milestone
Jun 8, 2026 4:00pm
ADA: Lilly's Foundayo pads case against semaglutide in diabetes
Jun 8, 2026 3:42pm
Eli Lilly is the ‘clear winner’ from ADA, RBC analyst says
Jun 8, 2026 3:12pm
More News
BMS taps ‘SVU’ detective to investigate myeloma in new campaign
Jun 8, 2026 1:17pm
ADA: Novo's Wegovy pill crosses hefty 3M prescription threshold
Jun 8, 2026 11:38am
FDA signs off on pediatric use of Pfizer's hemophilia treatment
Jun 8, 2026 10:32am
ADA: Amgen talks Repatha, GLP-1 hurdles as obesity plan advances
Jun 7, 2026 9:13pm
